ImageneBio IMA
NASDAQ IMA
$4.95 -0.06 (-1.20%)
As of: Sep 10, 2026 · 3:59 PM EDT

ImageneBio (IMA) EBT Margin (2020 - 2025)

ImageneBio's (IMA) quarterly EBT Margin came in at 759.62% in Q1 2025, down 735.28% quarter-over-quarter from 90.94% in Q3 2024.

Analysis

ImageneBio (IMA) EBT Margin (2020 - 2025) Analysis & Trends

ImageneBio has disclosed EBT Margin across 6 years of filings, most recently posting 759.62% for Q1 2025.

  • In Q1 2025, EBT Margin changed N/A year-over-year to 759.62%; the TTM figure through Sep 2025 stood at 1298.63% (down 58250.0% YoY), while the FY2023 annual figure was 745.94%, down 30565.0% from the prior year.
  • EBT Margin came in at 759.62% for Q1 2025 at ImageneBio, down from 90.94% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 13.83% in Q4 2021 to a low of 5376.44% in Q2 2022.
  • Average EBT Margin over 5 years is 988.0%, with a median of 372.4% recorded in 2021.
  • Year-over-year, EBT Margin jumped 4009537 bps in 2021 and plunged 501913 bps in 2022.
  • Over 5 years, EBT Margin stood at 13.83% in 2021, then slumped by 1970 bps to 258.66% in 2022, then sank by 1053 bps to 2981.94% in 2023, then jumped by 97 bps to 90.94% in 2024, then tumbled by 735 bps to 759.62% in 2025.
  • Per Business Quant data, the three most recent EBT Margin figures were 759.62% in Q1 2025, 90.94% in Q3 2024, and 2981.94% in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 27.53%
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -131.41%
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 41.75%
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 35.61%
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 35.78%
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -528.97%
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 13.77%
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 4.84%
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -20,427.46%
10 ImageneBio 42.89 Mn -92.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -759.63%
Sep 30, 2024 -90.94%
Dec 31, 2023 -2,981.94%
Sep 30, 2023 -1,463.54%
Jun 30, 2023 -854.04%
Mar 31, 2023 -267.63%
Dec 31, 2022 -258.66%
Sep 30, 2022 -270.82%
Jun 30, 2022 -5,376.44%
Mar 31, 2022 -497.61%
Dec 31, 2021 13.83%
Sep 30, 2021 -387.48%
Jun 30, 2021 -357.31%
Mar 31, 2021 -279.79%
Dec 31, 2020 -40,081.54%
Sep 30, 2020 -220.33%
Jun 30, 2020 -164.63%
Mar 31, 2020 -222.37%